Association between Prescription of Conventional or Atypical Antipsychotic Drugs and Mortality in Older Persons with Alzheimer’s Disease
Authors:
- Massimo MusiccoMMMassimo Musicco
- Katie PalmerKPKatie Palmer
- Antonio RussoARAntonio Russo
- Carlo CaltagironeCCCarlo Caltagirone
- Fulvio AdorniFAFulvio Adorni
- Carla PettenatiCPCarla Pettenati
- Luigi BisantiLBLuigi Bisanti
Open Access
- 1 April 2011
- journal article
- research article
- Published by S. Karger AG in Dementia and Geriatric Cognitive Disorders
- Vol. 31 (3) , 218-224
Abstract
Background/Aims: To evaluate whether dementia patients prescribed antipsychotic drugs have a higher mortality compared to unexposed patients, and to investigate whether there are differences in mortality associated with exposure to conventional versus atypical antipsychotic drugs. Methods: Retrospective population cohort study with information gathered from the Italian Health Information System. All 4,369 residents of Milan (Italy) aged 60 years or older who were newly prescribed an antidementia drug (donepezil, rivastigmine or galantamine) from January 2002 to June 2008 were included. All new users of antipsychotic drugs in this cohort were categorized according to conventional (n = 156) or atypical (n = 806) drug exposure. The mortality risks of users of conventional or atypical antipsychotics compared to nonusers were evaluated with survival analysis, considering exposure to antipsychotic drugs as a time-dependent variable. Results: Mortality was increased two- and fivefold in users of atypical and conventional antipsychotics, respectively, with respect to nonusers. Conclusions: Dementia patients prescribed antipsychotic drugs had a higher risk of death. This risk was highest for those prescribed conventional antipsychotics. At least part of the excess mortality may be due to the underlying neuropsychiatric symptoms that prompted the use of antipsychotics rather than a direct medication effect.Keywords
This publication has 24 references indexed in Scilit:
- All-Cause Mortality Associated With Atypical and Conventional Antipsychotics Among Nursing Home Residents With DementiaThe Journal of Clinical Psychiatry, 2009
- Management of agitation and aggression associated with Alzheimer diseaseNature Reviews Neurology, 2009
- Exposure to antipsychotics and risk of stroke: self controlled case series studyBMJ, 2008
- Survival times in people with dementia: analysis from population based cohort study with 14 year follow-upBMJ, 2008
- Mortality Risk in Patients With Dementia Treated With Antipsychotics Versus Other Psychiatric MedicationsAmerican Journal of Psychiatry, 2007
- Effectiveness of Atypical Antipsychotic Drugs in Patients with Alzheimer's DiseaseNew England Journal of Medicine, 2006
- Risk of Death in Elderly Users of Conventional vs. Atypical Antipsychotic MedicationsNew England Journal of Medicine, 2005
- Atypical antipsychotic drugs and risk of ischaemic stroke: population based retrospective cohort studyBMJ, 2005
- Olanzapine (Zyprexa): increased incidence of cerebrovascular events in dementia trialsCanadian Medical Association Journal, 2004
- Behavioral and Psychological Signs and Symptoms of Dementia: A Consensus Statement on Current Knowledge and Implications for Research and TreatmentInternational Psychogeriatrics, 1997